Neuland Laboratories Gestion
Gestion contrôle des critères 2/4
Le PDG Neuland Laboratories est Davuluri Rao, nommé en Aug2013, a un mandat de 11.25 ans. La rémunération annuelle totale est ₹ 148.30M, composée du salaire de 16.3% et des bonus 83.7%, y compris les actions et options de la société. détient directement 3.3% des actions de la société, d'une valeur de ₹ 6.81B. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 4.2 ans et 9.5 ans.
Informations clés
Davuluri Rao
Directeur général
₹148.3m
Rémunération totale
| Pourcentage du salaire du PDG | 16.3% |
| Durée du mandat du directeur général | 11.3yrs |
| Propriété du PDG | 3.3% |
| Durée moyenne d'occupation des postes de direction | 4.2yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 9.5yrs |
Mises à jour récentes de la gestion
Recent updates
Concerns Surrounding Neuland Laboratories' (NSE:NEULANDLAB) Performance
Nov 14
Neuland Laboratories Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Nov 09Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Is Well Worth Watching
Nov 08After Leaping 27% Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Are Not Flying Under The Radar
Oct 17Neuland Laboratories Limited's (NSE:NEULANDLAB) Shares Climb 44% But Its Business Is Yet to Catch Up
Aug 22Is Now The Time To Put Neuland Laboratories (NSE:NEULANDLAB) On Your Watchlist?
Aug 02Neuland Laboratories' (NSE:NEULANDLAB) Dividend Will Be Increased To ₹14.00
Jul 12Optimistic Investors Push Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Up 28% But Growth Is Lacking
Jul 02Neuland Laboratories' (NSE:NEULANDLAB) Upcoming Dividend Will Be Larger Than Last Year's
Jun 19Is Neuland Laboratories (NSE:NEULANDLAB) Using Too Much Debt?
Jun 12Neuland Laboratories (NSE:NEULANDLAB) Will Pay A Larger Dividend Than Last Year At ₹14.00
May 21There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump
Apr 19We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease
Apr 15Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%
Feb 17Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates
Feb 12Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Jan 05The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount
Nov 12Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today
Oct 27Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Aug 24Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically
Aug 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jul 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jun 21Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
May 14Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?
May 12Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly
Aug 30I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut
Feb 23The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically
Feb 03Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹3b |
| Jun 30 2024 | n/a | n/a | ₹3b |
| Mar 31 2024 | ₹148m | ₹24m | ₹3b |
| Dec 31 2023 | n/a | n/a | ₹3b |
| Sep 30 2023 | n/a | n/a | ₹3b |
| Jun 30 2023 | n/a | n/a | ₹2b |
| Mar 31 2023 | ₹58m | ₹20m | ₹2b |
| Dec 31 2022 | n/a | n/a | ₹1b |
| Sep 30 2022 | n/a | n/a | ₹831m |
| Jun 30 2022 | n/a | n/a | ₹651m |
| Mar 31 2022 | ₹30m | ₹15m | ₹638m |
| Dec 31 2021 | n/a | n/a | ₹593m |
| Sep 30 2021 | n/a | n/a | ₹731m |
| Jun 30 2021 | n/a | n/a | ₹742m |
| Mar 31 2021 | ₹34m | ₹11m | ₹806m |
| Dec 31 2020 | n/a | n/a | ₹540m |
| Sep 30 2020 | n/a | n/a | ₹384m |
| Jun 30 2020 | n/a | n/a | ₹257m |
| Mar 31 2020 | ₹22m | ₹10m | ₹162m |
| Dec 31 2019 | n/a | n/a | ₹321m |
| Sep 30 2019 | n/a | n/a | ₹257m |
| Jun 30 2019 | n/a | n/a | ₹216m |
| Mar 31 2019 | ₹13m | ₹10m | ₹164m |
| Mar 31 2018 | ₹5m | ₹3m | ₹121m |
Rémunération vs marché: La rémunération totale de Davuluri ($USD 1.76M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Indian ($USD 610.84K ).
Rémunération et revenus: La rémunération de Davuluri a augmenté de plus de 20 % au cours de l'année écoulée.
PDG
Davuluri Rao (49 yo)
11.3yrs
Titularisation
₹148,300,000
Compensation
Mr. Davuluri Sucheth Rao has been the Chief Executive Officer of Neuland Laboratories Limited since August 1, 2013, where Mr. Rao also served as its Chief Operating Officer. At Neuland, Sucheth has been re...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive Chairman & Chief Promoter and Member of Scientific Advisory Board | 40.8yrs | ₹148.50m | 26.37% ₹ 54.4b | |
| Vice Chairman & CEO | 11.3yrs | ₹148.30m | 3.3% ₹ 6.8b | |
| Vice Chairman & MD | 15.4yrs | ₹148.30m | 2.24% ₹ 4.6b | |
| Chief Financial Officer | 2yrs | pas de données | pas de données | |
| Chief Scientific Officer & Member of Scientific Advisory Board | less than a year | pas de données | pas de données | |
| Company Secretary & Compliance Officer | 12.8yrs | pas de données | pas de données | |
| Senior VP of Global Head Sales & BD | no data | pas de données | pas de données | |
| Chief Human Resources Officer | no data | pas de données | pas de données | |
| Senior Vice President of Global API Sales | no data | pas de données | pas de données | |
| Chief Procurement Officer | no data | ₹6.81m | pas de données | |
| President of Business Development & Contract Manufacturing | no data | pas de données | pas de données | |
| Chief Quality Officer | less than a year | pas de données | pas de données |
4.2yrs
Durée moyenne de l'emploi
54yo
Âge moyen
Gestion expérimentée: L'équipe de direction de NEULANDLAB est considérée comme expérimentée (ancienneté moyenne 4.2 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive Chairman & Chief Promoter and Member of Scientific Advisory Board | 40.8yrs | ₹148.50m | 26.37% ₹ 54.4b | |
| Vice Chairman & CEO | 21.3yrs | ₹148.30m | 3.3% ₹ 6.8b | |
| Vice Chairman & MD | 15.4yrs | ₹148.30m | 2.24% ₹ 4.6b | |
| Chief Scientific Officer & Member of Scientific Advisory Board | no data | pas de données | pas de données | |
| Independent Director | 2yrs | ₹2.90m | 0.00062% ₹ 1.3m | |
| Non-Executive Independent Director | 5.8yrs | ₹3.24m | pas de données | |
| Independent Director | 1.3yrs | ₹2.82m | pas de données | |
| Non-Executive Director & Member of Scientific Advisory Board | 15.1yrs | ₹2.85m | pas de données | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données | |
| Non-Executive Independent Director | 9.5yrs | ₹3.16m | pas de données | |
| Independent Director | 1.3yrs | ₹2.82m | pas de données | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données |
9.5yrs
Durée moyenne de l'emploi
78yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de NEULANDLAB sont considérés comme expérimentés (ancienneté moyenne 9.5 ans).